Delineation of the minimal region of loss at 13q14 in multiple myeloma

Genes Chromosomes and Cancer

Volumn 36, Issue 1, 2003, Pages 99-106

  Elnenaei, Manal O ^a   Hamoudi, Rifat A ^a   Swansbury, John ^a   Gruszka Westwood, Alicja M ^a   Brito Babapulle, Vasantha ^a   Matutes, Estella ^a   Catovsky, Daniel ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 13Q; CHROMOSOME DELETION; CHROMOSOME LOSS; DLEU1 GENE; DLEU2 GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PATHOGENESIS; PRIORITY JOURNAL; RFP2 GENE; TELOMERE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; DNA PROBES; FEMALE; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TUMOR CELLS, CULTURED;

EID: 0037226950     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10140     Document Type: Article

References (35)

1. Avet-Loiseau H, Facon T, Daviet A, Godon C, Rapp MJ, Harousseau JL, Grosbois B, Bataille R. 1999. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myelome. Cancer Res 59:4546-4550.
2. Avet-Loiseau H, Daviet A, Sauner S, Bataille R. 2000. Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13. Br J Haematol 111:1116-1117.
3. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM. 1996. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93:13931-13936.
4. Bezieau S, Devilder MC, Rondeau G, Cadoret E, Moisan JP, Moreau I. 1998. Assignment of 48 ESTs to chromosome 13 band q14.3 and expression pattern for ESTs located in the core region deleted in B-CLL. Genomics 52:369-373.
5. Bouyge-Moreau I, Rondeau G, Avet-Loiseau H, Andre MT, Bezieau S, Cherel M, Saleun S, Cadoret E, Shaikh T, De Angelis MM, Arcot S, Batzer M, Moisan JP, Devilder MC. 1997. Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3. Genomics 46:183-190.
6. Bullrich F, Veronese ML, Kitada S, Jurlander J, Caligiuri MA, Reed JC, Croce CM. 1996. Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia. Blood 88:3109-3115.
7. Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, Carrasco JL, Sole F, Cuesta B, Gullon A. 1997. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18:84-93.
8. Chang H, Bouman D, Boerkoel CF, Stewart AK, Squire JA. 1999. Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization. Leukemia 13:105-109.
9. Cigudosa JC, Calasanz MJ, Odero MD, Prosper F, Etxaniz A, Marin J, Rifon J, Gullon A, Rocha E. 1994. Cytogenetic data in 41 patients with multiple myeloma. Karyotype and other clinical parameters. Cancer Genet Cytogenet 78:210-213.
10. Cigudosa JC, Rao PH, Calasanz MJ, Odero MD, Michaeli J, Jhanwar SC, Chaganti RS. 1998. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization. Blood 91:3007-3010.
11. Corcoran MM, Rasool O, Liu Y, Iyengar A, Grander D, Ibbotson RE, Merup M, Wu X, Brodyansky V, Gardiner AC, Juliusson G, Chapman RM, Ivanova G, Tiller M, Gahrton G, Yankovsky N, Zabarovsky E, Oscier DG, Einhorn S. 1998. Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia. Blood 91:1382-1390.
12. Desikan R, Barlogie B, Sawyer J, Avers D, Tricot G, Badros A, Zangari M, Munshi NC, Anaissie E, Spoon D, Siegel D, Jagannath S, Vesole D, Epstein J, Shaughnessy J, Fassas A, Lim S, Roberson P, Crowley J. 2000. Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. Blood 95:4008-4010.
13. Dohner H, Stilgenbauer S, Fischer K, Bentz M, Lichter P. 1997. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes. Leukemia 11:S19-S24.
14. Drexter HG. 2001. The leukemia lymphoma cell lines, Second Ed. London: Academic Press.
15. Facon T, Avet-Loiseau H, Guillerm G, Moreau P, Genevieve F, Zandecki M, Lai JL, Leleu X, Jouet JP, Bauters F, Harousseau JL, Bataille R, Mary JY. 2001. Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy. Blood 97:1566-1571.
16. Flactif M, Zandecki M, Lai JL, Bernardi F, Obein V, Bauters F, Facon T. 1995. Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma. Leukemia 9:2109-2114.
17. Fonseca R, Oken MM, Harrington D, Bailey RJ, Van Wier SA, Henderson KJ, Kay NE, Van Ness B, Greipp PR, Dewald GW. 2001. Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy. Leukemia 15:981-986.
18. Gruszka-Westwood A, Hamoudi R, Matutes E, Tuset E, Catovsky D. 2001. p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood 97:3552-3558.
19. Kalachikov S, Migliazza A, Cayanis E, Fracchiolla NS, Bonaldo MF, Lawton L, Jelenc P, Ye X, Qu X, Chien M, Hauptschein R, Gaidano G, Vitolo U, Saglio G, Resegotti L, Brodjansky V, Yankovsky N, Zhang P, Soares MB, Russo J, Edelman IS, Efstratiadis A, Dalla-Favera R, Fischer SG. 1997. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics 42:369-377.
20. Kapanadze B, Kashuba V, Baranova A, Rasool O, van Everdink W, Liu Y, Syomov A, Corcoran M, Poltaraus A, Brodyansky V, Syomova N, Kazakov A, Ibbotson R, van den Berg A, Gizatullin R, Fedorova L, Sulimova G, Zelenin A, Deaven L, Lehrach H, Grander D, Buys C, Oscier D, Zabarovsky ER, Einhorn S, Yankovsky N. 1998. A cosmid and cDNA fine physical map of a human chromosome 13q14 region frequently lost in B-cell chronic lymphocytic leukemia and identification of a new putative tumor suppressor gene, Leu5. FEBS Lett 426:266-270.
21. Kapanadze B, Makeeva N, Corcoran M, Jareborg N, Hammarsund M, Baranova A, Zabarovsky E, Vorontsova O, Merup M, Gahrton G, Jansson M, Yankovsky N, Einhorn S, Oscier D, Grander D, Sangfelt O. 2000. Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14. Genomics 70:327-334.
22. Kastrinakis NG, Gorgoulis VG, Foukas PG, Dimopoulos MA, Kittas C. 2000. Molecular aspects of multiple myeloma. Ann Oncol 11:1217-1228.
23. Konigsberg R, Ackermann J, Kaufmann H, Zojer N, Urbauer E, Kromer E, Jager U, Gisslinger H, Schreiber S, Heinz R, Ludwig H, Huber H, Drach J. 2000a. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance. Leukemia 14:1975-1979.
24. Konigsberg R, Zojer N, Ackermann J, Kromer E, Kittler H, Fritz E, Kaufmann H, Nosslinger T, Riedl L, Gisslinger H, Jager U, Simonitsch I, Heinz R, Ludwig H, Huber H, Drach J. 2000b. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma. J Clin Oncol 18:804-812.
25. Liu Y, Corcoran M, Rasool O, Ivanova G, Ibbotson R, Grander D, Iyengar A, Baranova A, Kashuba V, Merup M, Wu X, Gardiner A, Mullenbach R, Poltaraus A, Hultstrom AL, Juliusson G, Chapman R, Tiller M, Cotter F, Gahrton G, Yankovsky N, Zabarovsky E, Einhorn S, Oscier D. 1997. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene 15:2463-2473.
26. Mertens D, Wolf S, Schroeter P, Schaffner C, Döhner H, Stilgenbauer S, Lichter P. 2002. Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. Blood 99:4116-4121.
27. Migliazza A, Bosch F, Komatsu H, Cayanis E, Martinotti S, Toniato E, Guccione E, Qu X, Chien M, Murty VV, Gaidano G, Inghirami G, Zhang P, Fischer S, Kalachikov SM, Russo J, Edelman I, Efstratiadis A, Dalla-Favera R. 2001. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood 97:2098-2104.
28. Rondeau G, Moreau I, Bezieau S, Cadoret E, Moisan JP, Devilder MC. 1999. Exclusion of Leu1 and Leu2 genes as tumor suppressor genes in 13q14.3-deleted B-CLL. Leukemia 13:1630-1632.
29. Sawyer JR, Waldron JA, Jagannath S, Barlogie B. 1995. Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet 82:41-49.
30. Shaughnessy J, Tian E, Sawyer J, Bumm K, Landes R, Badros A, Morris C, Tricot G, Epstein J, Barlogie B. 2000. High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH. Blood 96:1505-1511.
31. Stilgenbauer S, Nickolenko J, Wilhelm J, Wolf S, Weitz S, Dohner K, Boehm T, Dohner H, Lichter P. 1998. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene 16:1891-1897.
32. Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole DH, Naucke S, Sawyer JR. 1995. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyo-type abnormalities. Blood 86:4250-4256.
33. Wolf S, Mertens D, Schaffner C, Korz C, Dohner H, Stilgenbauer S, Lichter P. 2001. B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions. Hum Mol Genet 10:1275-1285.
34. Zandecki M, Lai JL, Facon T. 1996. Multiple myeloma: almost all patients are cytogenetically abnormal. Br J Haematol 94:217-227.
35. Zojer N, Konigsberg R, Ackermann J, Fritz E, Dallinger S, Kromer E, Kaufmann H, Riedl L, Gisslinger H, Schreiber S, Heinz R, Ludwig H, Huber H, Drach J. 2000. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood 95:1925-1930.